INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹140 Cr | ₹163 Cr | ₹164 Cr | ₹89 Cr | ₹60 Cr |
What is the latest Contingent Liabilities ratio of INDOCO REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹140 Cr |
| Mar2025 | ₹163 Cr |
| Mar2024 | ₹164 Cr |
| Mar2023 | ₹89 Cr |
| Mar2022 | ₹60 Cr |
How is Contingent Liabilities of INDOCO REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹140 Cr | -14.39 | |
| Mar2025 | ₹163 Cr | -0.60 | |
| Mar2024 | ₹164 Cr | 83.75 | |
| Mar2023 | ₹89 Cr | 48.09 | |
| Mar2022 | ₹60 Cr | - | |
Compare Contingent Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,975.7 Cr | -5.1% | -15.7% | -23.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -5.1% |
-15.7% |
-23.4% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses